Filana Therapeutics, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by ...
Q1 2026
May 7, 2026
FY 2025
Dec 30, 2025
Q4 2025
Q3 2025
Sep 30, 2025
Q2 2025
Jun 30, 2025